ANDG vs CBZ: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: CBZ is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ANDG and CBZ share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ANDG and CBZ exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Andersen Group is a holding company for Andersen, an independent professional services firm providing tax, valuation, and financial advisory services to individuals, family offices, businesses, and alternative investment funds. Founded by former Arthur Andersen partners and rebuilt as a non-audit firm, it spans private client services, business tax, alternative investment funds, and valuation. A defining feature is that it deliberately does not offer audit services, which frees it from auditor-independence constraints and lets it sell a broader set of advisory work. The company went public on the NYSE in December 2025 and is executing a roll-up strategy, folding member and collaborating firms from the global Andersen network (recent deals span Ireland, New Zealand, Nigeria, Uruguay, Canada, and more) into the public company.

Full ANDG guide

CBIZ, Inc. is a national professional-services firm that provides accounting and tax, financial advisory and consulting, employee benefits consulting, property and casualty insurance brokerage, and technology and managed IT services, primarily to middle-market businesses. It reports through three segments: Financial Services (the largest, covering accounting, tax, and advisory), Benefits and Insurance Services, and National Practices. Much of its revenue is recurring and fee-based, tied to compliance calendars, benefits renewals, and long-standing client relationships rather than a single product cycle. Its November 2024 acquisition of Marcum LLP, valued at roughly $2.3 billion, was the largest deal in its history and roughly doubled the company's scale, pushing combined annualized revenue toward $2.8 billion and making CBIZ the largest advisor of its kind in the US.

Full CBZ guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• ANDG drivers: Roll-up of the global Andersen network; Non-audit, advisory-led model.
• CBZ drivers: Marcum integration and scale synergies; Recurring, fee-based revenue base.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The company reported a large net loss in 2025 (around $130 million, driven by equity restructuring and profits interest units) and is guiding to another net loss in 2026, so it is not yet consistently profitable on a reported basis. For CBZ, cBIZ carries acquisition-related debt from the Marcum deal, so higher-for-longer interest rates and slower deleveraging are a risk to earnings.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ANDG if you believe its drivers more; CBZ if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ANDG and CBZ guides.

ANDG. As of July 2026, Andersen trades around $40.51 for a market cap near $4.57 billion on roughly $871 million of trailing revenue, so it is valued as a growth story rather than on current earnings (net income is negative). Management guides to roughly $955 million to $970 million of 2026 revenue and $213 million to $220 million of adjusted EBITDA while still expecting a reported net loss, so the reported bottom line and adjusted profitability diverge sharply. Figures reflect a company only months removed from its December 2025 IPO, so multiples and comparisons remain unusually noisy.

CBZ. CBIZ traded around $40 in July 2026, with a trailing P/E near 15 and a forward P/E closer to 9 on guided adjusted earnings, well below its multi-year average multiple. The valuation compression reflects the shift from acquisition-fueled 52% revenue growth in 2025 to guided low-to-mid single-digit organic growth in 2026. Reported quarterly results have at times included large non-operating gains from Marcum acquisition accounting, so adjusted EBITDA and free cash flow are the cleaner gauges of the underlying run-rate.

Headline figures (approximate, JULY 2026): ANDG shows share price ~$40.51, market cap ~$4.57B, revenue (ttm) ~$871M, revenue growth (yoy) ~13-16%; CBZ shows revenue (ttm) ~$2.8B, q1 2026 revenue ~$848.6M (+1.3% YoY), 2026 revenue guidance ~$2.8B to $2.9B (2-5% growth), 2026 adjusted eps guidance ~$4.00 to $4.10 (raised).

ANDG and CBZ are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ANDG and CBZ exposure against your real portfolio. It is not an investment adviser.